Cordlife Group Limited operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cordlife Group Limited with three other
health care providers in Asia:
TMC Life Sciences Bhd
sales of 151.71 million Malaysian Ringgits [US$38.20 million]
of which 100%
was Healthcare Industry),
Yamane Medical Corp
(5.80 billion Japanese Yen [US$52.27 million]
of which 97%
was Nursing Care Business), and
Nawaloka Hospitals PLC
based in Sri Lanka
(6.30 billion Sri Lanka Rupees [US$40.95 million]
Cordlife Group Limited reported sales of 59.96 million Singapore Dollars (US$45.25 million)
June of 2017.
a very small
increase of 0.6%
versus 2016, when the company's sales were 59.63 million Singapore Dollars.
Sales at Cordlife Group Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 108%).
Sales of Diagnostics saw an increase
that was more than double the company's growth rate: sales were up
68.4% in 2017, from
532,000.00 Singapore Dollars to 896,000.00 Singapore Dollars.
Not all segments of Cordlife Group Limited experienced an increase in sales in 2017:
sales of Banking fell 0.0% to 59.07 million Singapore Dollars.